Solid Dispersions-An Approach to Enhance the Dissolution Rate of Clopidogrel Bisulphate

 

Keerthi Manukonda*, Rama Rao N, Santhosh Aruna M, Lakshmi Prasanna J

Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur, A.P, India

*Corresponding Author E-mail: manukondakeerthi23@gmail.com

 

ABSTRACT:

Solid dispersions are one of the techniques to improve the solubility of the poorly soluble drugs. In this technique a poorly soluble drug is dispersed in the highly soluble hydrophilic matrix, two types of polymers are considered as carriers i.e., lactose, dextrose and cornstarch. Solubility is the basic step for formulation of different type of dosage forms. clopidogrel bisulphate is a BCS class II drug having low solubility and high permeability, used as ant platelet drug to inhibit blood clots in coronary artery disease, peripheral vascular disease and cerebrovascular disease. In this research article Clopidogrel bisulphate solubility has been increased by co-grinding method i.e.,one of the solid dispersion technique  lactose (1:5,1:10,1:15), dextrose (1:10,1:15) cornstarch:lactose (1:10,1:15) from three different polymers cornstarch: lactose showed 99%solubility than dextrose and lactose. In-vitro dissolution studies were conducted in PH 6.8 buffer.

 

KEYWORDS: Clopidogrel bisulphate, Solid dispersions, Antiplatelet, Cornstarch: Lactose.

 

 


INTRODUCTION:

Biopharmaceutical classification system (BCS) classified drugs based on the solubility and permeability. BCS class II drugs having low solubility and high permeability. The process of drug absorption occurs via dissolution. So it is important for drugs to increase the bioavailability. Many solubility enhancements techniques like micronisation, solvent evaporation technique, cogrinding, meltevaporation. meltcrystallisation, solid dispersions, microemulsion, hydrotrophy, precipitation, nanosuspensions are present. Among those solid dispersions is most widely used method [1] Solid dispersions mean inserting poorly soluble drug in to inert hydrophilic matrix. Several water soluble carriers such as methyl cellulose, urea, lactose, citric acid, polyvinyl pyrrolidone and polyethylene glycols 4000 and 6000 are used as carriers for solid dispersion.

 

Clopidogrel bisulfate is an anti-platelet drug, inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel prevents blood clots by irreversibly binding to the P2Y12 receptor on platelets, preventing Adenosine Diphosphate (ADP) from activating platelets. It belongs to a class of drugs called P2Y12 inhibitors.

 

Clopidogrel is used for preventing strokes, heart attacks, and death in individuals who have had a previous stroke, unstable angina, and heart attack or have peripheral arterial disease (PAD).[2]Drawback with this drug is its very low solubility (0.0099mg/ml) in biological fluids, which results in poor bioavailability after oral administration. In the present investigation to increase the solubility solid dispersion technique is adapted to the drug by using three hydrophilic carriers. Among them cornstarch: lactose showed best results compared to lactose and dextrose. In the future studies using these polymers many formulations can be developed [3].

 

MATERIALS:

Clopidogrel bisulphate was obtained as a gift sample from Hetero Drugs, Hyderabad. Lactose, dextrose, and cornstarch were obtained as a sample from Girijan Co-operative Corporation Ltd, Srisailam. All other ingredients are of analytical grade.

 

METHODS:

Clopidogrel bisulphate solid dispersions were prepared with three polymers using co-grinding method. Clopidogrel bisulfate (75mg) triturated   with different ratios of polymers   lactose (1:5, 1:10, 1:15), dextrose (1:10,1:15) cornstarch: lactose (1:10, 1:15) 20 minutes to ensure uniform mixing in geometrical ratio. Calibration data of pure dug in water, pH1.2, pH6.8 buffer were given in Table 1 and 2. Composition of the formulation and dissolution data of the pure drug mixture and dissolution data of the drug with polymers were given in the Table 3 and 4 respectively.

 

Selection of the carrier[4,5]

·         Be freely water-soluble with intrinsic rapid dissolution properties.

·         Be nontoxic and pharmacologically inert

·         Be heat stable with a low melting point for the melt method.

·         Be soluble in a variety of solvents and pass through a vitreous state upon solvent evaporation for the solvent method.

·         Be able to preferably increase the aqueous solubility of the drug.

 

Materials used as carriers for solid dispersions

S.NO

Class

Examples

1

Sugars

Dextrose, Sucrose, Galactose, Sorbitol, Maltose, Mannitol, Lactose

2

Acids

Citricacid, Succinicacid

3

Polymeric materials

Povidone, Polyethylene glycols, Hydroxy propyl cellulose

4

Insoluble polymers

Hydroxy propyl methyl cellulose, phthalate, Eudragit L-100

5

Surfactants

Polyoxyethylene sterate, Tweens and Spans

 

Standard solution:

75mg of Clopidogrel bisulphate was dissolved in methanol in a 50ml volumetric flask and the solution was made up to mark with methanol.

 

Procedure:

The standard solution of Clopidogrel bisulphate was subsequently diluted with 0.1N Hcl and pH6.8 and water to obtain a series of solutions containing 5, 10, 15, 20, 30, 45, 50,60,70 µg of Clopidogrel per ml. The absorbance of the solutions was measured in ELICO-SL 150UV spectrophotometer at 240nm.

 

Calibration curve for three buffers showed difference in solubility pH1.2 > water > pH 6.8. Acidic ph showed more solubility than basic pH.solid dispersions studied In vitro dissolution studies in Ph6.8 buffer.

 

Preparation of solid dispersions:

The solid dispersions were prepared by co grinding method clopidogrel bisulphate were mixed in various ratios lactose (1:5, 1:10, 1:15), dextrose (1:10, 1:15) cornstarch: lactose (1:10, 1:15).

 

Method of preparation of dispersion by co grinding method[6,7]

The required quantities of drug and carrier as given in table 4 .were triturated in a mortar and pestle thoroughly for 20min.the obtained powder was sifted through sieve number 80, solid dispersion equivalent to 75mg Clopidogrel was filled in to capsules.

Evaluation of solid dispersions:

The solid dispersions prepared were evaluated by the dissolution studies

 

Dissolution rate studies:

The dissolution rate testing of different Clopidogrel capsule formulations in table 5 was studied using USPXX1 dissolution rate testing apparatus (basket type) the basket was rotated at a speed of 50rpm and the dissolution fluid (900ml 6.8PHmedium) was maintained at a temperature of 37.5˚±0.5˚c.at specific time intervals a 5ml aliquot withdrawn and replaced to maintain sink condition. The obtained samples were analyzed at 240nm[8-10]

 

The dissolution profiles of Clopidogrel bisulphate solid dispersions from various formulations are given in the tables 6 and 7 and graphs 4, 5 and 6. 

 

CONCLUSION:

Solid dispersions of Clopidogrel bisulphate prepared using cornstarch: lactose by co grinding method showed better dissolution than the pure drug. Cornstarch: lactose showed more solubility of drug compared to dextrose and lactose.

 

ACKNOWLEDGEMENT:

The authors are thankful to Chalapathi Institute of Pharmaceutical Sciences for providing facilities for bringing out this work. 

 

Table 1: Calibration of Clopidogrel bisulphate in water at 240nm

S.

NO

Concentration (ug/ml)

Trail I

Trail II

Trail III

Absorbance

1

5

0.280

0.271

0.269

0.273

2

10

0.382

0.369

0.389

0.380

3

15

0.487

0.479

0.483

0.483

4

20

0.584

0.562

0.568

0.571

5

25

0.678

0.658

0.668

0.668

6

30

0.785

0.783

0.775

0.781

7

35

0.869

0.864

0.864

0.865

8

40

0.890

0.899

0.890

0.895

 

Table 2: Calibration of Clopidogrel bisulphate in PH1.2 at 240nm

S.

NO

Concentration(ug/ml)

Trail  I

Trail II

Trail III

Absorbance

1

10

0.215

0.248

0.218

0.227

2

20

0.326

0.354

0.325

0.335

3

30

0.434

0.478

0.445

0.452

4

40

0.545

0.578

0.567

0.563

5

50

0.658

0.689

0.680

0.675

6

60

0.741

0.798

0.790

0.776

7

70

0.849

0.890

0.891

0.876

 

Table 3: Calibration of Clopidogrel bisulphate in PH6.8 at 240nm

S.

NO

Concentration(ug/ml)

Trail I

Trail II

Trail III

Absorbance

1

10

0.194

0.256

0.239

0.229

2

20

0.304

0.345

0.340

0.331

3

30

0.426

0.458

0.451

0.447

4

40

0.575

0.560

0.568

0.567

5

50

0.686

0.654

0.689

0.676

6

60

0.796

0.780

0.784

0.786

7

70

0.898

0.894

0.890

0.894

 

Table 4: Amount of Clopidogrel bisulphate and carriers in solid dispersions

S. No

Formulation

Amt of drug (mg)

Amount of carrier (mg)

1

L1(1:5)

75

375

2

L2(1:10)

75

750

3

L3(1:20)

75

1500

4

D1(1:10)

75

750

5

D2(1:15)

75

1125

6

CS:L1(1:10

75

750

7

CS:L2(1:15)

75

1125

 

Table 5: List of different Clopidogrel capsule formulations

S. No.

Formulation

Composition

1

A

Pure drug( CL.G)

2

B

Pure drug in 0.1Hcl

3

C

Pure drug in 6.8 buffer

4

L1

CL.G:LACTOSE(1:5)

5

L2

CL.G:LACTOSE(1:10)

6

L3

CL.G:LACTOSE(1:20)

7

D1

CL.G:DEXTROSE(1:10)

8

D2

CL.G:DEXTROSE(1:15)

9

CS:L1

CL.G:CORNSTARCH:LACTOSE(1:10)

10

CS:L2

CL.G:CORNSTARCH:LACTOSE(1:15)

 

Table 6: Dissolution profiles of Clopidogrel bisulphate from capsules containing pure drug in a different mediums

S.NO

Time(mts)

%Clopidogrel dissolved

Water

Ph1.2

Ph6.8

1

5

29.493       

63.122

17.4

2

10

32.083

72.618

18.72

3

20

36.309

84.669

21.96

4

30

42.316

87.076

22.8

5

45

48.681

90.28

24.12

 

Figure 1: Calibration curve of  a drug in acidic medium

 

Figure 2 : calibration curve of a drug in water

 

Figure 3 : calibration curve of a drug in basic medium

 

Figure 4 : Comparison of pure drug dissolution in three mediums

 


 

Table 7: Dissolution profiles of Clopidogrel bisulphate from capsules containing pure drug and different ratios of carriers in ph6.8 buffer

S. NO

Time (mts)

%Clopidogrel bisulphate dissolved

L1

L2

L3

D1

D2

CS:L1

CS:L2

1

5

42.744

53.04

69.72

58.08

59.28

52.44

58.32

2

10

46.272

57.12

77.04

64.68

69.12

62.88

66.24

3

20

49.452

60.24

78.96

71.64

76.08

66.84

80.88

4

30

54.456

63.12

84.12

77.61

83.04

83.76

93.12

5

45

57.852

72.6

95.52

84.12

97.68

84.24

99.09

 


 

Figure5: Comparison of Three Polymers Solid Dispersions Highest Concentration

 

REFERENCES:

1.        Varun Raj Vemula, Venkateshwarlu Lagishetty. Solubility Enhancement Techniques. International Journal of Pharmaceutical Sciences Review and Research. 2010; 5(1) 41-51.

2.        Redya Naik, Aishwarya Madikanti, T.Sunitha .Formulation and Evaluation of oral dispersible tablets of Clopidogrel bisulfate by solid dispersion method. Indo American Journal of Pharmaceutical Research.2014; 4(7) 3152-3162

3.        Sahitya, B. Krishnamoorthy M. Muthukumaran, G. Kishore. Formulation and Evaluation of fast dissolving tablets using solid dispersion of Clopidogrel bisulphate. Int. Journal Adv Pharm Gen Res 2014; 2(1): 15- 23.

4.        Balvinder Dhillon, Narendra, Goyal, Rishabha Malviya and Pramod K. Sharma. Poorly Water Soluble Drugs: Change in Solubility for Improved Dissolution Characteristics a Review. Global Journal of Pharmacology, 2014;8 (1): 26-35.

5.        Varun Raj Vemula, Venkateshwarlu Lagishetty, Srikanth Lingala. Solubility enhancement techniques. International Journal of Pharmaceutical Sciences Review and Research. 2010; 5(1), 41-52.

6.        K. Rama Koteswara Rao, K. Rajya Lakshmi. Design, development and evaluation of clopidogrel bisulfate floating tablets. Int J Pharma Investig 2014;4,19-26.

7.        Kotta Kranthi Kumar, K. Sampath Kumar, G. Satheesh. Formulation and Evaluation of Clopidogrel bisulfate immediate release tablets. IJPT 2013; 5(2): 5481-5504.

8.        M. Santhosh Aruna, Kishore Babu, Madhurilatha Thadanki. Solid dispersions an approach to enhance the dissolution rate of Clopidogrel bisulphate. International Journal of Research in Pharmacy and Chemistry.2011;1/(4),780-788.

9.        Dhirendra K. Solid dispersions: a Review, Pak. J. Pharm. Sci 2009; 22(2):234-246.

10.     Mogal S. A, Gurjar P. N, Yamgar D. S and Kamod A.C. Solid dispersion technique for improving solubility of some poorly soluble drugs. Scholars Research Library Der Pharmacia Lettre, 2012, 4 (5):1574-1586

 

 

Received on 26.09.2014          Accepted on 30.10.2014        

© Asian Pharma Press All Right Reserved

Asian J. Res. Pharm. Sci. 4(4): Oct.-Dec. 2014; Page 165-168